1946
DOI: 10.3181/00379727-61-15309
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of an Inactivated Tissue Culture Scrub Typhus Vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

1947
1947
1955
1955

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 0 publications
0
14
0
Order By: Relevance
“…I t also has been employed in earlier studies of scrub typhus vaccine in this laboratory (17). T h e 101st to 128th yolk sac passages of the Kostival strain provided material for the present work.…”
Section: ~0mentioning
confidence: 99%
See 2 more Smart Citations
“…I t also has been employed in earlier studies of scrub typhus vaccine in this laboratory (17). T h e 101st to 128th yolk sac passages of the Kostival strain provided material for the present work.…”
Section: ~0mentioning
confidence: 99%
“…HI blood taken in January, 1943, from a soldier who contracted the disease in the B u n a -G u n a area of New Guinea. T h e Karp agent was used previously in this laboratory for the prepara- t.ion of vaccine by two different methods (16,17). Suspensions of tissue of the 27th to 41st yolk sac passages were used in the current studies.…”
Section: ~0mentioning
confidence: 99%
See 1 more Smart Citation
“…Methods applicable to the other rickettsiae are not satisfactory here. So far clear protec tion has been evidenced only following intraperitoneal vaccination and intraperitoneal challenge (6,43,44), and subcutaneous vacci nation has not protected against intraperitoneal challenge. How ever, the protection afforded by intraperitoneal vaccination ap pears to be specific (6).…”
Section: Immunological Relationships Among the Rickettsiaementioning
confidence: 99%
“…The development of a vaccine against scrub typhus is still essentially in the laboratory stages. Vaccines have been prepared from the spleens or lungs of infected mice, cotton rats, and white rats (6,15,60) and from agar tissue cultures of rickettsia (46). Aside from the fact that the manufacture of these vaccines on a large scale by these methods would be difficult (60), their protective value for man has yet to be determined.…”
Section: Vaccinesmentioning
confidence: 99%